Figure 2.
Effect of AR42 on gem numbers in type II SMA fibroblasts. GM03813 type II SMA fibroblasts were treated with differing doses of AR42, AR19, 4PBA or TSA for 5 days (n = 3/dose/drug). The number of SMN-positive gems within 100 randomly selected nuclei was counted. Representative images are shown for GM03813 SMA fibroblasts treated with 1 μM AR42 (A), 1 μM AR19 (B), 1 μM 4PBA (C), 100 nM TSA (D) or DMSO (E) as well as for GM03814 carrier fibroblasts (F). The scale bars (yellow lines) represent 10 μm. The gem count analysis was expressed as (G) the number of gems per 100 nuclei, (H) the proportion of cells containing gems and (I) the proportion of cells containing multiple gems. The data are presented as mean ± standard error. The asterisk (*) denotes a statistically significant (p ≤ 0.05; one-way ANOVA with Bonferroni post hoc test) difference between drug- and vehicle-treated GM03813 SMA cells.
